anxiety
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Undergraduate students enrolled in the nursing course at the University Center of Patos de Minas; students in their second, fourth, sixth, eighth, and tenth semesters of the year 2024; individuals over eighteen years of age; participants who agree to collaborate with the research by signing the Informed Consent Form; students who answer the sociodemographic instrument and the Hospital Anxiety and Depression Scale; students who agree to use the essential oil for the period and frequency proposed by the study
Exclusion criteria
Exclusion criteria: Students who are not present on the day of data collection; participants who do not correctly complete the questionnaire; academics who do not perform aromatherapy according to recommendations; students who already use herbal remedies, medicinal plants, antidepressants, anxiolytics, or any other complementary practice; individuals unable to attend any course; students on leave or with suspended institutional enrollment
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Expected outcome 1: A decrease in anxiety levels is expected among nursing students, as measured by the Hospital Anxiety and Depression Scale, after the use of aromatherapy with bergamot oil, based on a statistically significant variation observed in pre- and post-intervention scores;Outcome 1: A significant reduction in participants' anxiety symptoms was observed, verified by applying the Hospital Anxiety and Depression Scale, where the treatment group showed a greater reduction from 10.80 to 7.70 with Cohen's d of 0.82, indicating a large effect, compared to the placebo group, which reduced from 11.18 to 8.63 with Cohen's d of 0.64, indicating a moderate effect;Expected outcome 2: A decrease in depression levels is expected among nursing students, as measured by the Hospital Anxiety and Depression Scale, after the use of aromatherapy with bergamot oil, based on a statistically significant variation observed in pre- and post-intervention scores;Outcome found 2: A significant reduction in participants' depression symptoms was observed, verified through the application of the Hospital Anxiety and Depression Scale, where the treatment group showed a greater reduction from 7.10 to 4.21 with Cohen's d equal to 0.70, indicating a moderate to large effect, compared to the placebo group, which reduced from 6.92 to 5.54 with Cohen's d equal to 0.41, indicating a small to moderate effect | — |
Secondary
| Measure | Time frame |
|---|---|
| No secondary outcomes are expected | — |
Countries
BR
Contacts
Universidade de Franca